{"nct_id":"NCT04269200","title":"Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2020-05-05","start_date_type":"ACTUAL","primary_completion_date":"2024-07-08","primary_completion_date_type":"ACTUAL","completion_date":"2027-04-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}